伯基特淋巴瘤的瘤微环境:不同的免疫特征与不同的临床行为
Maria Chiara Siciliano1, Giorgio Bertolazzi2,3, Gaia Morello2
1Department of Medical Biotechnologies, University of Siena, Siena, Italy.
Blood advances
|June 11, 2024
概括
带有颗粒状反应的伯基特淋巴瘤显示出一种促炎性瘤微环境,与典型的"星空"伯基特淋巴瘤所见的M2极化不同. 这种免疫格局的差异表明了伯基特淋巴瘤的新治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 伯基特淋巴瘤 (BL) 具有由巨细胞主导的瘤微环境 (TME),形成"星空"模式.
- 一些BL病例表现出颗粒状反应,可能表明有利的预后和自发回归.
研究的目的:
- 为了全面描述爱斯坦-巴尔病毒阳性 (EBV+) BL与颗粒状反应的免疫景观.
- 为了将这些病例与EBV+和EBV阴性 (EBV-) BL进行比较,这些病例呈现出典型的"星空"模式.
主要方法:
- 使用NanoString nCounter平台进行基因表达分析.
- 通过多重检测和联合免疫染色验证.
- 不监督对差异表达的基因进行聚类,以确定不同的样本组.
主要成果:
- 三个不同的星团出现了:带有粒状反应的BL,带有星空的EBV+BL和带有星空的EBV-BL.
- 具有颗粒状反应的BL表现出一种促炎性TME特征.
- 带有星空图案的BL显示M2极化和突起体反应,暗区和表观遗传特征的升调.
结论:
- 在颗粒状反应的BL和星空模式的BL之间,免疫反应的信号存在显著差异.
- 与瘤相关的巨细胞和表观遗传调节器代表了在伯基特淋巴瘤中新型免疫治疗策略的潜在治疗标.
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Immunotherapy
514
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
514


